The state‐of‐play and future of antibody therapeutics☆
Sign Up to like & getrecommendations! Published in 2017 at "Advanced Drug Delivery Reviews"
DOI: 10.1016/j.addr.2016.11.004
Abstract: Abstract It has been over four decades since the development of monoclonal antibodies (mAbs) using a hybridoma cell line was first reported. Since then more than thirty therapeutic antibodies have been marketed, mostly as oncology,… read more here.
Keywords: therapeutic antibodies; antibody; play future; future antibody ... See more keywords